Elfabrio Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Pegunigalsidase alfa

Indications/Uses

Adults w/ confirmed Fabry disease.

Dosage/Direction for Use

IV 1 mg/kg infusion every 2 wk. Enzyme replacement therapy (ERT)-experienced patient weighing >100 kg Total infusion vol: 500 mL. Infusion rate: 2.78 mL/min, 70-100 kg Total infusion vol: 250 mL. Infusion rate: 1.39 mL/min, <70 kg Total infusion vol: 150 mL. Infusion rate: 0.83 mL/min. ERT-naïve patient weighing >100 kg Total infusion vol: 500 mL. Infusion rate: 1.38 mL/min, 70-100 kg Total infusion vol: 250 mL. Infusion rate: 1 mL/min, <70 kg Total infusion vol: 150 mL. Infusion rate: 0.63 mL/min.

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

A16AB20 - pegunigalsidase alfa ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.

Regulatory Classification

POM

Presentation/Packing

Form

Elfabrio conc for soln for infusion 2 mg/mL

Packing/Price

1's

Elfabrio

Manufacturer:

Chiesi Farmaceutici